Developer docs
API playgroundTry for free, no card

Search company profiles

Optima Pharmaceutical

Full company profile

uuid000yvc6

Namestring
Optima Pharmaceutical
Legal namestring
Optima Pharmazeutische GmbH
Websiteurl
optimapharma.de
Company typeenum
Private
Founded yearint
1984
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHallbergmoos, Germany
HQ citystring
Hallbergmoos
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
liposomal medical devices, dry eye treatment, ophthalmology products, ear and nasal care, private label pharmaceuticals
Industry2 codes
PRIMARYHLAHAJAF
Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAIADAF
Eye, Ear & Nasal Care
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines
NAICS code3 codes
  • Ophthalmic Goods Manufacturing339115
  • Pharmaceutical and Medicine Manufacturing3254
  • Optical Goods Retailers45613
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Pharmaceutical Preparations2834
Product category
Ophthalmic & ENT Medical Devices
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Branded Medical Device Sales
TypeOne Time License
Description

Sale of proprietary branded medical devices under product brands including Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, and others across ophthalmology, ENT, and pulmonology segments.

optimapharma.de
2Private Label / OEM Licensing
TypeLicensing Royalties
Description

In-licensing and private label manufacturing agreements where Optima provides its formulations and manufacturing expertise to partners for distribution under partner brand names. Revenue generated through licensing fees and product supply.

optimapharma.de
3Direct Consumer Sales (E-commerce)
TypeOne Time License
Description

Products available for purchase directly via Amazon and pharmacy ordering links on product pages, suggesting direct-to-consumer and e-commerce retail channels.

optimapharma.de
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 11 records shown
1TEARS AGAIN
Description

Liposomal eye spray and eye drops for dry eye treatment.

optimapharma.de
+10 more records
Core offering1 text field

Optima Pharmaceutical develops, manufactures, and distributes a portfolio of preservative-free, liposomal medical devices focused on ophthalmology (especially dry eye and eyelid care), ENT (ear and nasal care), and pulmonology/dry-mouth applications. The company sells its products under its own brands — Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, tima-oculav, and others — through pharmacies, opticians, hearing-care specialists, and Amazon, while also offering in-licensing and private-label (OEM) manufacturing partnerships to pharmaceutical and medical device distributors across Europe, Australia, New Zealand, and Canada.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Products successfully distributed in 20+ countries
+1 more record
Product overview1 text field

Optima Pharmaceutical is an owner-managed, medium-sized family business that develops, manufactures, and distributes innovative medical devices. The company operates in three therapeutic areas: ophthalmology (the core competency, particularly for dry eye syndrome treatment), ear, nose and throat medicine (ENT), and pulmonology. The product portfolio includes Tears Again (liposomal eye spray and eye drops for dry eyes), BlephaCura (eyelid care products), LipoNit (comprehensive dry eye management line including eye sprays, hyaluronic acid drops, eyelid care products, and warming masks), tima-oculav (sterile phosphate buffer eye wash for chemical burns), OtoCura (ear spray for earwax management and ear canal care), LipoNasal (liposomal nasal spray for sinus and allergy relief), LipoSaliva (mouth spray for dry mouth/xerostomia), and LipoAerosol (respiratory care). The company also offers in-licensing and private label solutions to partners, with products distributed in over 20 countries through branded and private label solutions.

Product and service13 records
1Tears Again
CategoryOphthalmology — dry eye treatment
Description

Liposomal eye spray and eye drops that stabilize the protective lipid layer of the tear film and gently moisturize all forms of dry eye, intended for adult consumers and recommended for screen work, air-conditioned environments, and contact lens wear.

2Lipo Nit
CategoryOphthalmology — dry eye management
Description

Product line including liposomal eye sprays that stabilize and protect the tear film, hyaluronic acid eye drops, eyelid care fluid, eyelid hygiene wipes, and a warming gel mask — used for full dry eye management and sold exclusively via opticians and hearing care professional shops.

3BlephaCura
CategoryOphthalmology — eyelid care
Description

Daily eyelid care and lid margin hygiene products for managing blepharitis (eyelid inflammation), dry, irritated, and sensitive eyes, supporting the natural function of the meibomian glands across warming and cleansing steps.

4tima-oculav
CategoryOphthalmology — emergency eye care
Description

Sterile phosphate-buffer eye wash for first aid after chemical burns, chemically neutralizing H+ or OH- ions from acids or alkalis and requiring significantly less volume than water; a single-use medical device for emergency eye flushing.

5OtoCura
CategoryENT — ear care
Description

Ear spray that supports the ear's natural self-cleaning by gently softening and loosening earwax (cerumen) while protecting sensitive ear canal skin with a conditioning blend of olive, almond, and calendula oils; also improves comfort for hearing aid and in-ear headphone users.

6LipoNasal
CategoryENT — nasal care
Description

Liposomal nasal spray with dexpanthenol that moisturizes nasal and sinus mucous membranes, supports natural protective and clearance functions, relieves chronic sinusitis and allergic rhinitis symptoms, and uses phospholipid liposomes that physically interact with respiratory viruses.

7LipoSaliva
CategoryPulmonology / Respiratory Care — dry mouth
Description

Liposomal oral spray containing phospholipids for long-lasting moistening and care of oral and throat mucous membranes in patients with dry mouth (xerostomia), suitable for medication-, radiation-, or CPAP/oxygen-therapy-induced dryness and clinically proven to improve discomfort and taste disorders.

8LipoAerosol
CategoryPulmonology / Respiratory Care
Description

Respiratory care product line for treating irritative cough, laryngitis, and tracheotomy care, designed to support and moisten irritated airways.

9Isogutt
CategoryOphthalmology — eye drops
Description

Eye drop product line for acute treatment of irritated ocular mucous membranes.

10Lento Nit K
CategoryOphthalmology — eye care
Description

Ophthalmology product line for eye care and dry eye management, complementing the Lipo Nit range of sprays, drops, and eyelid-care products.

11Nozovent
CategoryENT — nasal device
Description

Nasal device product for nasal care and breathing support.

12Otovent
CategoryENT — ear pressure device
Description

Ear pressure equalization device used to relieve ear pain when flying and diving by equalizing pressure in the middle ear.

13In-Licensing and Private Label (OEM) Partnerships
CategoryContract Manufacturing / Private Label Services
Description

B2B offering in which Optima provides its proprietary liposomal formulations, regulatory documentation, and manufacturing expertise to pharmaceutical and medical device distributors for in-licensing or private-label distribution under partner brand names across the ophthalmology, ENT, and pulmonology categories.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership10 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-01-01
Description

Optima has been supporting World Vision since 2019 in disseminating the FMNR (Farmer Managed Natural Regeneration) method, developed by Tony Rinaudo (Right Livelihood Award winner). Regenerative reforestation projects in Kenya, Senegal, Ghana, and Uganda focus on climate protection, fighting desertification, hunger, and poverty by improving crop yields.

Strategic tierMinorTypeOthers
Description

Optima facilitates tree planting through the Plant-for-the-Planet organization as part of its climate neutrality and reforestation commitment.

Strategic tierMinorTypeOthers
Description

Optima supports tree planting through Bergwaldprojekt eV as part of its sustainability commitment. Over 100,000 trees have been facilitated through this and Plant-for-the-Planet partnerships.

4DFGE (Institute for Energy, Ecology and Economy)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

DFGE provides annual Corporate Carbon Footprint calculations for the Optima Group, covering Scope 1, 2, and 3 emissions. DFGE also issues the climate neutrality certification for the company. This partnership is central to Optima's climate neutrality strategy, first certified in 2014.

optimapharma.de
5German Society of Ophthalmology (DOG)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Optima has been the exclusive sponsor of the DOG Science Award for Dry Eye and Blepharitis/MGD since 2014, awarded annually in cooperation with the Professional Association of German Ophthalmologists (BVA). This research award supports outstanding clinical and basic scientific work in dry eye and meibomian gland dysfunction.

optimapharma.de
6Professional Association of German Ophthalmologists (BVA)
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Joint sponsor with DOG of the annual DOG Science Award for Dry Eye and Blepharitis/MGD, supported by Optima Pharmazeutische GmbH. Awards outstanding research in ophthalmology and dry eye disease since 2014.

optimapharma.de
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Optima joined the UN Global Compact in 2014, committing to ten universally recognized principles in human rights, labour standards, environmental protection, and anti-corruption. The company publishes annual sustainability reports on the UN Global Compact website.

8Circius Pharma AB
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Application images for Otovent (ear pressure regulation device for flying and diving) are sourced from Circius Pharma AB, suggesting a product/image licensing or distribution relationship.

optimapharma.de
9Dermatest
Strategic tierMinorTypeOthers
Description

OtoCura ear spray was independently tested and awarded the 'VERY GOOD' rating by Dermatest in June 2025, providing third-party dermatological certification of skin compatibility and safe use.

optimapharma.de
1040+ Distribution Partners (Europe, Australia, New Zealand, Canada)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Optima maintains a network of 40+ distribution partners across Europe, Australia, New Zealand, and Canada. Products are sold in more than 20 countries under both branded products and private label solutions through these partnerships.

optimapharma.de
Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Rohto Pharmaceutical Co., Ltd.
TypeBroad incumbent
Description

Japanese OTC eye care leader (Rohto V, Mentholatum) with broad dry eye, lid, and contact lens comfort products globally. Comparable OTC ophthalmic portfolio but a much larger international consumer health player than Optima.

TypeBroad incumbent
Description

Largest dedicated eye-care company globally with pharma, surgical, and OTC vision care (e.g., Systane, OPTI-FREE). Comparable in ophthalmic medical device and dry-eye category but operating at vastly greater scale.

TypeEmerging player
Description

Heidelberg-based clinical-stage ophthalmology company developing water-free (EyeSol) therapies for dry eye and other ocular surface diseases. Comparable as a German/Spanish ophthalmology innovator working on novel tear-film chemistry, though focused on Rx versus Optima's OTC/device positioning.

4Croma-Pharma GmbH
TypeDirect peer
Description

Austrian family-owned company specializing in ophthalmology (surgical, intraocular lenses, eye drops) and aesthetic medicine. Comparable as a DACH-region specialty ophthalmology company with overlapping lid and ocular surface product categories.

5Santen Pharmaceutical Co., Ltd.
TypeBroad incumbent
Description

Japan-headquartered global specialty ophthalmology company with deep dry eye, glaucoma, and ocular surgery franchises (including preservative-free formulations comparable to Tears Again). Comparable therapeutic focus, larger scale and global reach than Optima.

TypeBroad incumbent
Description

Global eye-health company with broad OTC dry eye, lid hygiene (Soothe, Blink), and ophthalmology portfolios distributed through pharmacy and ECP channels. Comparable in product categories but vastly larger scale than Optima.

TypeDirect peer
Description

German family-owned pharmaceutical/medical device company focused on ophthalmology, ENT, and related specialty areas (e.g., hyaluronic acid eye drops, nasal sprays). Closely comparable to Optima in geography, therapeutic mix, Mittelstand structure, and OTC/pharmacy distribution orientation.

TypeDirect peer
Description

Independent French ophthalmology specialty company with a leading preservative-free dry eye, lid hygiene, and ocular surface portfolio distributed across Europe. Highly comparable to Optima in independent specialty-pharma positioning, preservative-free medical device focus, and European partnership-driven GTM.

TypeDirect peer
Description

German specialist in ophthalmic products including eye drops, lid care, and contact lens solutions. Directly comparable as a same-size German Mittelstand competitor in preservative-free eye drops and eyelid hygiene.

TypeDirect peer
Description

Switzerland-based OTC ophthalmology/ENT specialist selling preservative-free eye drops, ear, and sinus products via pharmacy channels in Europe and North America. Similar independent, mid-sized specialty positioning to Optima with comparable distribution model.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Optima Pharmaceutical

Ophthalmic & ENT Medical Devicesoptimapharma.de

Optima Pharmaceutical firmographics

Firmographics
Name
Optima Pharmaceutical
Legal name
Optima Pharmazeutische GmbH
Website
https://optimapharma.de
Company type
Private
Founded year
1984
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Optima Pharmaceutical industry classification

Industry
Product category
Ophthalmic & ENT Medical Devices
NAICS
Ophthalmic Goods Manufacturing (339115), Pharmaceutical and Medicine Manufacturing (3254), Optical Goods Retailers (45613)
SIC
Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAHAJAF
Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Ophthalmic Devices (Vision Care & Surgical)
SECONDARYHLAIADAF
Eye, Ear & Nasal Care
Healthcare & Life Sciences/Pharmaceuticals/Over-the-Counter (OTC) Medicines

Keywords

  • Liposomal medical devices
  • Dry eye treatment
  • Ophthalmology products
  • Ear and nasal care
  • Private label pharmaceuticals

Where Optima Pharmaceutical is headquartered

Location

Headquarters

HQ city
Hallbergmoos
HQ country
Germany
HQ region
Europe

Offices1 record

Markets served

Optima Pharmaceutical business model

Business model
GTM type
B2B and B2C
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Branded Medical Device Sales: Sale of proprietary branded medical devices under product brands including Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, and others across ophthalmology, ENT, and pulmonology segments.
  2. Private Label / OEM Licensing: In-licensing and private label manufacturing agreements where Optima provides its formulations and manufacturing expertise to partners for distribution under partner brand names. Revenue generated through licensing fees and product supply.
  3. Direct Consumer Sales (E-commerce): Products available for purchase directly via Amazon and pharmacy ordering links on product pages, suggesting direct-to-consumer and e-commerce retail channels.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels3 records

Optima Pharmaceutical product offering

Product offering

Core offering

Optima Pharmaceutical develops, manufactures, and distributes a portfolio of preservative-free, liposomal medical devices focused on ophthalmology (especially dry eye and eyelid care), ENT (ear and nasal care), and pulmonology/dry-mouth applications. The company sells its products under its own brands — Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, tima-oculav, and others — through pharmacies, opticians, hearing-care specialists, and Amazon, while also offering in-licensing and private-label (OEM) manufacturing partnerships to pharmaceutical and medical device distributors across Europe, Australia, New Zealand, and Canada.

Product overview

Optima Pharmaceutical is an owner-managed, medium-sized family business that develops, manufactures, and distributes innovative medical devices. The company operates in three therapeutic areas: ophthalmology (the core competency, particularly for dry eye syndrome treatment), ear, nose and throat medicine (ENT), and pulmonology. The product portfolio includes Tears Again (liposomal eye spray and eye drops for dry eyes), BlephaCura (eyelid care products), LipoNit (comprehensive dry eye management line including eye sprays, hyaluronic acid drops, eyelid care products, and warming masks), tima-oculav (sterile phosphate buffer eye wash for chemical burns), OtoCura (ear spray for earwax management and ear canal care), LipoNasal (liposomal nasal spray for sinus and allergy relief), LipoSaliva (mouth spray for dry mouth/xerostomia), and LipoAerosol (respiratory care). The company also offers in-licensing and private label solutions to partners, with products distributed in over 20 countries through branded and private label solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • TEARS AGAIN: Liposomal eye spray and eye drops for dry eye treatment.
  • Lipo Nit
  • LipoNasal
  • OtoCura
  • tima-oculav
  • BlephaCura
  • Isogutt
  • Lento Nit K
  • LipoAerosol
  • LipoSaliva
  • Nozovent

Products and services

  • Tears Again Liposomal eye spray and eye drops that stabilize the protective lipid layer of the tear film and gently moisturize all forms of dry eye, intended for adult consumers and recommended for screen work, air-conditioned environments, and contact lens wear.
  • Lipo Nit Product line including liposomal eye sprays that stabilize and protect the tear film, hyaluronic acid eye drops, eyelid care fluid, eyelid hygiene wipes, and a warming gel mask — used for full dry eye management and sold exclusively via opticians and hearing care professional shops.
  • BlephaCura Daily eyelid care and lid margin hygiene products for managing blepharitis (eyelid inflammation), dry, irritated, and sensitive eyes, supporting the natural function of the meibomian glands across warming and cleansing steps.
  • tima-oculav Sterile phosphate-buffer eye wash for first aid after chemical burns, chemically neutralizing H+ or OH- ions from acids or alkalis and requiring significantly less volume than water; a single-use medical device for emergency eye flushing.
  • OtoCura Ear spray that supports the ear's natural self-cleaning by gently softening and loosening earwax (cerumen) while protecting sensitive ear canal skin with a conditioning blend of olive, almond, and calendula oils; also improves comfort for hearing aid and in-ear headphone users.
  • LipoNasal Liposomal nasal spray with dexpanthenol that moisturizes nasal and sinus mucous membranes, supports natural protective and clearance functions, relieves chronic sinusitis and allergic rhinitis symptoms, and uses phospholipid liposomes that physically interact with respiratory viruses.
  • LipoSaliva Liposomal oral spray containing phospholipids for long-lasting moistening and care of oral and throat mucous membranes in patients with dry mouth (xerostomia), suitable for medication-, radiation-, or CPAP/oxygen-therapy-induced dryness and clinically proven to improve discomfort and taste disorders.
  • LipoAerosol Respiratory care product line for treating irritative cough, laryngitis, and tracheotomy care, designed to support and moisten irritated airways.
  • Isogutt Eye drop product line for acute treatment of irritated ocular mucous membranes.
  • Lento Nit K Ophthalmology product line for eye care and dry eye management, complementing the Lipo Nit range of sprays, drops, and eyelid-care products.
  • Nozovent Nasal device product for nasal care and breathing support.
  • Otovent Ear pressure equalization device used to relieve ear pain when flying and diving by equalizing pressure in the middle ear.
  • In-Licensing and Private Label (OEM) Partnerships B2B offering in which Optima provides its proprietary liposomal formulations, regulatory documentation, and manufacturing expertise to pharmaceutical and medical device distributors for in-licensing or private-label distribution under partner brand names across the ophthalmology, ENT, and pulmonology categories.

Quantifiable outcome

  • Products successfully distributed in 20+ countries
  • +1 more outcomes

Companies that use Optima Pharmaceutical

Customer profile

Segments3 records

Ideal customer profiles2 records

Optima Pharmaceutical technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Optima Pharmaceutical partnerships and signals

Strategic signal

Partnerships

Ten partnerships are on record, tiered core and minor.

  • World VisioncoreStrategic or Co-development Partner · 1 January 2019Optima has been supporting World Vision since 2019 in disseminating the FMNR (Farmer Managed Natural Regeneration) method, developed by Tony Rinaudo (Right Livelihood Award winner). Regenerative reforestation projects in Kenya, Senegal, Ghana, and Uganda focus on climate protection, fighting desertification, hunger, and poverty by improving crop yields.
  • Plant-for-the-PlanetminorOthersOptima facilitates tree planting through the Plant-for-the-Planet organization as part of its climate neutrality and reforestation commitment.
  • Bergwaldprojekt eVminorOthersOptima supports tree planting through Bergwaldprojekt eV as part of its sustainability commitment. Over 100,000 trees have been facilitated through this and Plant-for-the-Planet partnerships.
  • DFGE (Institute for Energy, Ecology and Economy)coreStrategic or Co-development PartnerDFGE provides annual Corporate Carbon Footprint calculations for the Optima Group, covering Scope 1, 2, and 3 emissions. DFGE also issues the climate neutrality certification for the company. This partnership is central to Optima's climate neutrality strategy, first certified in 2014.
  • German Society of Ophthalmology (DOG)coreStrategic or Co-development PartnerOptima has been the exclusive sponsor of the DOG Science Award for Dry Eye and Blepharitis/MGD since 2014, awarded annually in cooperation with the Professional Association of German Ophthalmologists (BVA). This research award supports outstanding clinical and basic scientific work in dry eye and meibomian gland dysfunction.
  • Professional Association of German Ophthalmologists (BVA)coreStrategic or Co-development PartnerJoint sponsor with DOG of the annual DOG Science Award for Dry Eye and Blepharitis/MGD, supported by Optima Pharmazeutische GmbH. Awards outstanding research in ophthalmology and dry eye disease since 2014.
  • United Nations Global CompactcoreStrategic or Co-development PartnerOptima joined the UN Global Compact in 2014, committing to ten universally recognized principles in human rights, labour standards, environmental protection, and anti-corruption. The company publishes annual sustainability reports on the UN Global Compact website.
  • Circius Pharma ABminorChannel Partner/ Reseller/ DistributorApplication images for Otovent (ear pressure regulation device for flying and diving) are sourced from Circius Pharma AB, suggesting a product/image licensing or distribution relationship.
  • DermatestminorOthersOtoCura ear spray was independently tested and awarded the 'VERY GOOD' rating by Dermatest in June 2025, providing third-party dermatological certification of skin compatibility and safe use.
  • 40+ Distribution Partners (Europe, Australia, New Zealand, Canada)coreChannel Partner/ Reseller/ DistributorOptima maintains a network of 40+ distribution partners across Europe, Australia, New Zealand, and Canada. Products are sold in more than 20 countries under both branded products and private label solutions through these partnerships.

Scale indicators3 records

Recent moves4 records

Expansion highlights6 records

Optima Pharmaceutical competitors and assessment

Company assessment

Broad incumbents

  • Rohto Pharmaceutical Co., Ltd. Japanese OTC eye care leader (Rohto V, Mentholatum) with broad dry eye, lid, and contact lens comfort products globally. Comparable OTC ophthalmic portfolio but a much larger international consumer health player than Optima.
  • Alcon Inc. Largest dedicated eye-care company globally with pharma, surgical, and OTC vision care (e.g., Systane, OPTI-FREE). Comparable in ophthalmic medical device and dry-eye category but operating at vastly greater scale.
  • Santen Pharmaceutical Co., Ltd. Japan-headquartered global specialty ophthalmology company with deep dry eye, glaucoma, and ocular surgery franchises (including preservative-free formulations comparable to Tears Again). Comparable therapeutic focus, larger scale and global reach than Optima.
  • Bausch + Lomb (Bausch Health): Global eye-health company with broad OTC dry eye, lid hygiene (Soothe, Blink), and ophthalmology portfolios distributed through pharmacy and ECP channels. Comparable in product categories but vastly larger scale than Optima.

Emerging players

  • Novaliq GmbH: Heidelberg-based clinical-stage ophthalmology company developing water-free (EyeSol) therapies for dry eye and other ocular surface diseases. Comparable as a German/Spanish ophthalmology innovator working on novel tear-film chemistry, though focused on Rx versus Optima's OTC/device positioning.

Direct peers

  • Croma-Pharma GmbH: Austrian family-owned company specializing in ophthalmology (surgical, intraocular lenses, eye drops) and aesthetic medicine. Comparable as a DACH-region specialty ophthalmology company with overlapping lid and ocular surface product categories.
  • Ursapharm Arzneimittel GmbH: German family-owned pharmaceutical/medical device company focused on ophthalmology, ENT, and related specialty areas (e.g., hyaluronic acid eye drops, nasal sprays). Closely comparable to Optima in geography, therapeutic mix, Mittelstand structure, and OTC/pharmacy distribution orientation.
  • Laboratoires Théa: Independent French ophthalmology specialty company with a leading preservative-free dry eye, lid hygiene, and ocular surface portfolio distributed across Europe. Highly comparable to Optima in independent specialty-pharma positioning, preservative-free medical device focus, and European partnership-driven GTM.
  • OmniVision GmbH: German specialist in ophthalmic products including eye drops, lid care, and contact lens solutions. Directly comparable as a same-size German Mittelstand competitor in preservative-free eye drops and eyelid hygiene.
  • Similasan AG: Switzerland-based OTC ophthalmology/ENT specialist selling preservative-free eye drops, ear, and sinus products via pharmacy channels in Europe and North America. Similar independent, mid-sized specialty positioning to Optima with comparable distribution model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Optima Pharmaceutical financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Optima Pharmaceutical leadership team

Management profile

Number of profiles

Profiles2 records

Optima Pharmaceutical subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Optima Pharmaceutical funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Optima Pharmaceutical M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Optima Pharmaceutical

What does Optima Pharmaceutical do?

Optima Pharmaceutical develops, manufactures, and distributes a portfolio of preservative-free, liposomal medical devices focused on ophthalmology (especially dry eye and eyelid care), ENT (ear and nasal care), and pulmonology/dry-mouth applications. The company sells its products under its own brands — Tears Again, Lipo Nit, BlephaCura, OtoCura, LipoNasal, LipoSaliva, tima-oculav, and others — through pharmacies, opticians, hearing-care specialists, and Amazon, while also offering in-licensing and private-label (OEM) manufacturing partnerships to pharmaceutical and medical device distributors across Europe, Australia, New Zealand, and Canada.

Is Optima Pharmaceutical a public or private company?

Optima Pharmaceutical is a private company. It is classified as family owned and is currently operating.

When was Optima Pharmaceutical founded?

Optima Pharmaceutical was founded in 1984. It employs 11 to 50 people.

Where is Optima Pharmaceutical based?

Optima Pharmaceutical is headquartered in Hallbergmoos, Germany, in the Europe region.

How does Optima Pharmaceutical make money?

Three revenue lines are on record. Branded Medical Device Sales are the primary driver. The others are private Label / OEM Licensing and direct Consumer Sales (E-commerce).

Who are Optima Pharmaceutical's main competitors?

Broad incumbents on record are Rohto Pharmaceutical Co., Ltd., Alcon Inc., Santen Pharmaceutical Co., Ltd. and Bausch + Lomb (Bausch Health). Novaliq GmbH is listed as an emerging player. Direct peers are Croma-Pharma GmbH, Ursapharm Arzneimittel GmbH, Laboratoires Théa, OmniVision GmbH and Similasan AG.

Does Optima Pharmaceutical have an API?

No public API is recorded for Optima Pharmaceutical.

What industry is Optima Pharmaceutical in?

Optima Pharmaceutical's product category is Ophthalmic & ENT Medical Devices. Its primary akta.pro industry code is HLAHAJAF, Dry Eye & Ocular Surface Devices (Meibography, Tear Osmolarity, IPL, Thermal Pulsation), with a secondary code of HLAIADAF, Eye, Ear & Nasal Care. Its NAICS code is 339115 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals